Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
44.72
+0.60 (1.36%)
May 4, 2026, 11:49 AM EDT - Market open
Travere Therapeutics Market Cap
Travere Therapeutics has a market cap or net worth of $4.13 billion as of May 4, 2026. Its market cap has increased by 219.50% in one year.
Market Cap
4.13B
Enterprise Value
4.16B
1-Year Change
219.50%
Ranking
Category
Stock Price
$44.72
Market Cap Chart
Since December 31, 2012, Travere Therapeutics's market cap has increased from $40.40M to $4.13B, an increase of 10,124.70%. That is a compound annual growth rate of 41.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 4.07B | 19.04% |
| Dec 31, 2025 | 3.42B | 151.45% |
| Dec 31, 2024 | 1.36B | 101.24% |
| Dec 29, 2023 | 675.60M | -49.94% |
| Dec 30, 2022 | 1.35B | -28.99% |
| Dec 31, 2021 | 1.90B | 36.59% |
| Dec 31, 2020 | 1.39B | 128.10% |
| Dec 31, 2019 | 610.00M | -34.65% |
| Dec 31, 2018 | 933.40M | 12.70% |
| Dec 29, 2017 | 828.20M | 15.95% |
| Dec 30, 2016 | 714.30M | 2.44% |
| Dec 31, 2015 | 697.30M | 113.37% |
| Dec 31, 2014 | 326.80M | 153.92% |
| Dec 31, 2013 | 128.70M | 218.56% |
| Dec 31, 2012 | 40.40M | - |
| Dec 31, 2012 | 40.40M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CRISPR Therapeutics AG | 4.97B |
| Dianthus Therapeutics | 4.76B |
| Ligand Pharmaceuticals | 4.56B |
| Legend Biotech | 4.36B |
| Crinetics Pharmaceuticals | 4.09B |
| Telix Pharmaceuticals | 3.81B |
| Veradermics | 3.77B |
| ACADIA Pharmaceuticals | 3.76B |